| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Caris Life Sciences, Inc. (CAI) has 15 insiders with recent SEC Form 4 filings, including 4 buys and 2 sells. CAI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 20.26M | $327.14M | - | |
| Other | 2.30M | $37.07M | - | |
| 10% | 1.01M | $16.32M | - | |
| Pres | 460.8K | $7.44M | - | |
| Dir | 220.2K | $3.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Power Luke Thomas | See Remarks | Sale+OE | 62,250 | $26.58 | $1,654,461.30 | -23.7% | -29.8% | - | |
| Nov 7, 2025 | Denton John Russel | See Remarks | Buy | 4,184 | $24.09 | $100,792.56 | +83.7% | -17.0% | - | |
| Nov 7, 2025 | Spetzler David Baxley | President | Buy | 400 | $23.85 | $9,540.00 | - | -17.0% | - | |
| Jun 20, 2025 | Brille Brian J | See Remarks | Buy | 30,000 | $21.00 | $630,000.00 | +22.7% | +22.7% | - | |
| Jun 20, 2025 | Denton John Russel | See Remarks | Buy | 7,500 | $21.00 | $157,500.00 | +6.5% | +22.7% | - |